ATE417059T1 - Verfahren zur herstellung hochreiner nicht toxischer toxinfragmente - Google Patents

Verfahren zur herstellung hochreiner nicht toxischer toxinfragmente

Info

Publication number
ATE417059T1
ATE417059T1 AT00958898T AT00958898T ATE417059T1 AT E417059 T1 ATE417059 T1 AT E417059T1 AT 00958898 T AT00958898 T AT 00958898T AT 00958898 T AT00958898 T AT 00958898T AT E417059 T1 ATE417059 T1 AT E417059T1
Authority
AT
Austria
Prior art keywords
ligand
toxin
highly pure
producing highly
pure non
Prior art date
Application number
AT00958898T
Other languages
English (en)
Inventor
John A Chaddock
F C G Alexander
Keith A Foster
Original Assignee
Health Prot Agency
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Health Prot Agency filed Critical Health Prot Agency
Application granted granted Critical
Publication of ATE417059T1 publication Critical patent/ATE417059T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1282—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Clostridium (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/811—Peptides or proteins is immobilized on, or in, an inorganic carrier

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
AT00958898T 1999-09-13 2000-09-13 Verfahren zur herstellung hochreiner nicht toxischer toxinfragmente ATE417059T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9921592.3A GB9921592D0 (en) 1999-09-13 1999-09-13 Preparation of highly pure toxin fragments

Publications (1)

Publication Number Publication Date
ATE417059T1 true ATE417059T1 (de) 2008-12-15

Family

ID=10860807

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00958898T ATE417059T1 (de) 1999-09-13 2000-09-13 Verfahren zur herstellung hochreiner nicht toxischer toxinfragmente

Country Status (7)

Country Link
US (1) US7193066B1 (de)
EP (1) EP1212361B1 (de)
AT (1) ATE417059T1 (de)
AU (1) AU7030700A (de)
DE (1) DE60041067D1 (de)
GB (1) GB9921592D0 (de)
WO (1) WO2001019863A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9617671D0 (en) * 1996-08-23 1996-10-02 Microbiological Res Authority Recombinant toxin fragments
US7192596B2 (en) * 1996-08-23 2007-03-20 The Health Protection Agency Ipsen Limited Recombinant toxin fragments
US8012491B2 (en) * 1996-08-23 2011-09-06 Syntaxin, Ltd. Recombinant toxin fragments
US7368532B2 (en) 1999-12-02 2008-05-06 Syntaxin Limited Constructs for delivery of therapeutic agents to neuronal cells
MX340772B (es) * 2009-02-19 2016-07-26 Merz Pharma Gmbh & Co Kgaa Medios y metodos para fabricar neurotoxina altamente pura.
GB0903006D0 (en) 2009-02-23 2009-04-08 Syntaxin Ltd Modified non-cytotoxic proteases
LT2490986T (lt) * 2009-10-21 2018-11-26 Revance Therapeutics, Inc. Nekompleksinio botulino neurotoksino gryninimo būdai ir sistemos
KR20110046178A (ko) * 2009-10-28 2011-05-04 엘지전자 주식회사 이동 단말기
KR101134146B1 (ko) 2010-05-31 2012-04-19 메덱스젠 주식회사 국소 근마비 효과를 갖는 비확산형 보툴리눔 독소와 그의 정제방법
CN109206286A (zh) * 2018-11-02 2019-01-15 南京理工大学 一种可用作起爆药的胶囊结构铝热剂及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5601826A (en) 1989-06-30 1997-02-11 The United States Of America As Represented By The Department Of Health And Human Services Peptide which produces protective immunity against tetanus
DE4037809A1 (de) * 1990-11-28 1992-06-04 Yehia Mohammed Yousif Anwendungen von staphylokokkal neutrale phosphatase und 70 kd protein
NZ337543A (en) 1994-10-24 2002-06-28 Allergan Inc Composition comprising avian antitoxin against clostridial neurotoxin protein and method for producing recombinant antitoxin proteins are provided for
ZA983690B (en) * 1998-04-02 1999-02-04 Synsorb Biotech Inc Solid support matrices containing a toxin binding oligosaccharide

Also Published As

Publication number Publication date
EP1212361A1 (de) 2002-06-12
DE60041067D1 (de) 2009-01-22
EP1212361B1 (de) 2008-12-10
GB9921592D0 (en) 1999-11-17
WO2001019863A1 (en) 2001-03-22
US7193066B1 (en) 2007-03-20
AU7030700A (en) 2001-04-17

Similar Documents

Publication Publication Date Title
DE60009511D1 (de) Nematizide trifluorbutene
BR0316375A (pt) Diazinopirimidinas
DE60114002D1 (de) VERFAHREN ZUR HERSTELLUNG KRISTALLINEr PARTIKEL ZUR INHALATION
DK1242115T3 (da) Kemisk programmerbar immunitet
EA199901016A1 (ru) 9-оксим-производные эритромицина
DE60022230D1 (de) Verfahren zur herstllung von clarithromycin polymorphen und polymorph iv
CY1108808T1 (el) Ενωσεις μοτιλιδης
ATE417059T1 (de) Verfahren zur herstellung hochreiner nicht toxischer toxinfragmente
BR0109975A (pt) Método para produzir ansamitocinas
SE0003476D0 (sv) Compounds
ATE516027T1 (de) Orazamid orotat zur vorbeugung von leberschäden
DK0613687T3 (da) Anvendelse af pregnanderivat til behandling af tumorer
PT1107793E (pt) Conjugados de dextrano-leptina, composicoes farmaceuticas e processos relacionados
DK0775158T3 (da) Cyclopeptolider
DE60226313D1 (de) Verwendung von sesquiterpene enthaltenden zusammenstellungen zur behandlung von krebs
ID27440A (id) Proses untuk menyiapkan penengah-penengah
PT1276722E (pt) Inibidores de naftamidina-uroquinase
ATE339423T1 (de) Verfahren zur herstellung von 4'-o-substituierten 4'-demethyl-1 desoxypodophyllotoxinderivaten und geometrischen isomeren davon ,und antikrebspräparat, das diese enthält
WO2001068066A3 (en) A composition comprising camptothecin or a camptothecin derivative and an alkylating agent for the treatment of cancer
ATE397615T1 (de) 6-o-alkyl-2-nor-2-substituierte ketolidderivate
ATE254469T1 (de) Verfahren zur verminderung der renalen aufnahme von antikörperfragmenten
ATE265418T1 (de) Neue substituierte 3-phenoxy- und 3- phenylalkyloxy-2-phenyl-propylamine
DE69834504D1 (de) Nicht-toxische immun-stimulierende enterotoxin-zusammensetzungen
PT777471E (pt) Metodo de inibicao da biosintese de leucotrieno
EE200100242A (et) Alfa-arüülalkaanhapete valmistamismeetod

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties